市场调查报告书
商品编码
1466360
PPG 生物感测器市场:按产品、应用、分销和最终用途 - 2024-2030 年全球预测PPG Biosensors Market by Product (Pulse Oximeters, Smart Watches, Smart Wristbands), Application (Blood Pressure, Blood-oxygen Saturation, Heart Rate Monitoring), Distribution, End Use - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
PPG生物感测器市场规模预计2023年为6.4171亿美元,2024年达到7.2614亿美元,预计2030年将达到15.3336亿美元,复合年增长率为13.25%。
光电体积描记法 (PPG) 生物感测器是用于检测组织微血管床血容量的非侵入性装置。这些感测器使用光源和检测器来测量光吸收的变化,并将其与血流的脉动成分相关联。这使得一些应用程式能够监测心率、血氧饱和度甚至血压等生理参数。 PPG 生物感测器由于尺寸紧凑且易于使用,通常被纳入穿戴式科技和医疗设备中。同时,人口老化的加剧和心血管疾病盛行率的增加正在增加对PPG生物感测器的需求。对照护现场设备的需求不断增长也推动了对 PPG 生物感测器的需求。然而,与 PPG 生物感测器相关的技术限制和不准确问题给主要企业和最终用户带来了重大挑战。将新技术融入 PPG 生物感测器使公司能够在全球范围内保持敏捷性和响应能力。 PPG生物感测器广泛应用于医院、个人健身、家庭监控和其他技术创新领域,人们对健康和健身日益增长的兴趣正在为主要参与者创造巨大的商机。
主要市场统计 | |
---|---|
基准年[2023] | 64171万美元 |
预测年份 [2024] | 7.2614亿美元 |
预测年份 [2030] | 15.3336亿美元 |
复合年增长率(%) | 13.25% |
将PPG技术整合到产品智慧型手錶和腕带中,支援心率监测和呼吸功能
PPG 生物感测器处于穿戴式健康监测革命的前沿。采用 PPG 技术的脉动式血氧监测仪系统是一种非侵入式设备,可测量使用者血液中的氧饱和度 (SpO2),提供有关呼吸功能的重要资讯。同样,智慧型手錶将 PPG 生物感测器集成为其高级功能集的一部分,可实现连续心率监测和其他健康相关指标。智慧腕带利用这项技术来迎合健身和健康产业的需求,采用侵入性较小且可靠的 PPG 感测器来追踪心率、睡眠模式和身体活动。这些产品以易于使用的形式呈现,为消费者提供来自 PPG 生物感测器的各种健康见解,并补充他们的生活方式。
应用增加 PPG 生物感测器在血压监测中的使用,以发现潜在的慢性疾病
光电体积描记法(PPG)生物感测器对于各种健康参数的非侵入性临床监测至关重要。 PPG 感测器有潜力用于无袖带血压估算监测系统,为传统血压监测仪提供便捷的替代方案,并实现连续即时监测。对于血氧饱和度 (SpO2),PPG 生物感测器在脉搏血氧饱和度分析仪中至关重要。这些设备对于在临床环境和个人健康设备中评估患者的血氧水平至关重要。此外,PPG 技术在心率监测方面非常重要,可以检测组织微血管床中的血液容量变化,并为评估心臟健康状况、追踪健身水平和检测潜在心律不整提供有价值的资料。将 PPG 生物感测器融入穿戴式技术将大大提高不引人注目且持续监测这些生命体征的能力,从而促进预防医学和个人化医疗保健策略。
区域洞察
在美洲,特别是在美国和加拿大,对医疗保健创新和可穿戴技术的日益关注正在显着推动对 PPG 生物感测器的需求。消费者意识和采用是美国的重点关注点,许多公司在新技术和消费者健康应用方面投入大量资金。由于主要科技公司的存在以及对医疗保健研发的大量投资,该地区的 PPG 生物感测器市场非常强劲,重点关注持续健康监测和个人健康。同时,在欧盟 (EU) 国家,人口老化、医疗成本增加以及医疗基础设施完善,对 PPG 生物感测器的需求量很大。欧盟严格的法律规范可确保产品符合高安全性和品质标准,从而培养消费者的信任和采用。学术界和工业界之间的研究津贴和合作研究也在蓬勃发展,为 PPG 生物感测器在临床环境中的高级应用铺平了道路。随着医疗保健现代化的进步,特别是在波湾合作理事会(GCC)国家,该市场正在中东和非洲兴起,推动了市场的成长。此外,亚太地区以其消费者需求和购买行为的多样性而闻名,尤其是中国,可穿戴技术的迅速采用。中国政府透过对医疗基础设施和研发的投资提供支持,加上中阶人口的不断增长,正在为主要参与者创造巨大的市场机会。在日本,完善的电子产业和严格的品质标准使得消费者对专注于老化和远端健康监测解决方案需求的 PPG 生物感测器充满信心。快速发展的高科技产业和数位转型使印度成为 PPG 生物感测器具有巨大潜力的有吸引力的市场。
FPNV定位矩阵
FPNV定位矩阵对于评估PPG生物感测器市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市场占有率分析
市场占有率分析是一种综合工具,可对 PPG 生物感测器市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。
4.竞争评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。
5. 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。
1.PPG生物感测器市场的市场规模和预测是多少?
2. PPG 生物感测器市场预测期间需要考虑投资的产品、细分市场、应用和领域有哪些?
3.PPG生物感测器市场的技术趋势和法规结构是什么?
4.PPG生物感测器市场主要厂商的市场占有率是多少?
5.进入PPG生物感测器市场的合适型态和策略手段是什么?
[195 Pages Report] The PPG Biosensors Market size was estimated at USD 641.71 million in 2023 and expected to reach USD 726.14 million in 2024, at a CAGR 13.25% to reach USD 1,533.36 million by 2030.
Photoplethysmography (PPG) biosensors are non-invasive devices significantly used to detect blood volume in the microvascular bed of tissue. These sensors employ a light source and a photodetector to measure variations in light absorption, which correlates with the pulsatile component of the blood flow. This allows for monitoring physiological parameters such as heart rate, blood oxygen saturation, and even blood pressure in some applications. PPG biosensors are commonly integrated into wearable technology and medical devices due to their compact size and ease of use. Meanwhile, the growing aging population and the increasing prevalence of cardiovascular disorders have bolstered the demand for PPG biosensors. The rising demand for point-of-care devices has also propelled the demand for PPG biosensors. However, the technical limitations and inaccuracy issues associated with the PPG biosensors are a significant challenge faced by key companies and end users. Companies are continuously integrating new technologies within PPG biosensors to remain agile within the global landscape. Their widespread use spans hospitals, personal fitness, and home monitoring, driven by technological innovations, and a heightened focus on health and fitness presents significant opportunities for the key players.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 641.71 million |
Estimated Year [2024] | USD 726.14 million |
Forecast Year [2030] | USD 1,533.36 million |
CAGR (%) | 13.25% |
Product: Integration of PPG technology in smart watches and wristbands to cater to heart rate monitoring and respiratory function
PPG biosensors are at the forefront of the wearable health monitoring revolution. Pulse oximeters, which utilize PPG technology, are non-invasive devices that measure the oxygen saturation level (SpO2) of the user's blood, providing vital information about respiratory function. Similarly, smartwatches have integrated PPG biosensors as part of their advanced feature set, enabling continuous heart rate monitoring and other health-related metrics. Smart wristbands leverage this technology to cater to the fitness and wellness industry, incorporating less invasive and reliable PPG sensors that track heart rate, sleep patterns, and physical activity. These products offer consumers various health insights derived from PPG biosensors, showcased in accessible, user-friendly formats that complement their lifestyles.
Application: Increasing usage of PPG biosensors in blood pressure monitoring to detect potential chronic disorders
Photoplethysmography (PPG) biosensors are pivotal in non-invasive clinical monitoring of various health parameters. PPG sensors are employed in cuffless monitoring systems for blood pressure estimation, offering a convenient alternative to traditional sphygmomanometers, potentially allowing for continuous, real-time monitoring. In blood-oxygen saturation (SpO2), PPG biosensors are integral to pulse oximeters. These instruments have become indispensable in clinical settings and personal health devices for assessing patient blood oxygenation. Moreover, PPG technology is critical in heart rate monitoring to detect blood volume changes in the microvascular bed of tissue, providing valuable data for assessing cardiac health, tracking fitness levels, and detecting potential arrhythmias. Incorporating PPG biosensors into wearable technologies has significantly enhanced the ability to monitor these vital signs continuously discreetly, facilitating preventive medicine and personalized healthcare strategies.
Regional Insights
In the Americas, particularly the United States and Canada, a growing emphasis on healthcare innovation and wearable technology has significantly driven the demand for PPG biosensors. The United States strongly emphasizes consumer awareness and adoption, with numerous companies investing heavily in new technologies and consumer health applications. The presence of key technology players and substantial investments in healthcare R&D contribute to a robust market for PPG biosensors, focusing on continuous health monitoring and personal wellness in this region. On the other hand, The European Union (EU) countries exhibit a high demand for PPG biosensors, driven by an aging population, increased healthcare expenditure, and well-established healthcare infrastructure. The EU's stringent regulatory framework ensures products meet high safety and quality standards, fostering consumer trust and adoption. Research grants and collaboration between academia and industry are frequent, paving the way for advanced applications of PPG biosensors in clinical settings. In the Middle East and Africa, the market is emerging, with growth driven by increasing healthcare modernization, especially in Gulf Cooperation Council (GCC) countries. Moreover, the Asia Pacific region is notably diverse in consumer needs and purchasing behaviors, with China having rapidly adopted wearable technologies. The Chinese government's support through investment in healthcare infrastructure and R&D, coupled with a growing middle-class population, presents significant market opportunities for the key players. In Japan, the well-established electronics industry and stringent quality standards lead to high consumer trust in PPG biosensors, focusing on aging demographics and the need for remote health monitoring solutions. With its burgeoning tech industry and digital transformation, India has become an attractive market with vast potential for PPG biosensors, especially considering its large population and increasing health awareness.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the PPG Biosensors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the PPG Biosensors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the PPG Biosensors Market, highlighting leading vendors and their innovative profiles. These include Ams-OSRAM AG, Analog Devices, Inc., Apple Inc., Contec Medical Systems Co., Ltd., Dragerwerk AG & Co. KGaA, Edwards Lifesciences Corporation, Empatica Inc., Fitbit, Inc., GE HealthCare Technologies Inc., Hill-Rom Holdings, Inc., Innovative Sensor Technology IST AG, Koninklijke Philips N.V., Masimo Corp., MediaTek Inc., MedNet GmbH, Medtronic PLC, Murata Manufacturing Co., Ltd., OSI Systems, Inc., Renesas Electronics Corporation, Reveal Biosensors, Inc., SEIKO EPSON CORPORATION, Senbiosys SA, Shenzhen Goodix Technology Co., Ltd., Shimmer Research Ltd., Siemens Healthineers AG, Silicon Laboratories Inc., SlateSafety, Inc., Texas Instruments Incorporated, Valencell, Inc., and Vishay Intertechnology, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the PPG Biosensors Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the PPG Biosensors Market?
3. What are the technology trends and regulatory frameworks in the PPG Biosensors Market?
4. What is the market share of the leading vendors in the PPG Biosensors Market?
5. Which modes and strategic moves are suitable for entering the PPG Biosensors Market?